SCHEMBL9745970

SCHEMBL9745970

CSc1nc(-c2ccc(Cl)cc2)c(-c2ccc(Cl)cc2)[nH]1

nearest known ligand 0.76

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 5/20 0.76
▸ PTGS2 P35354 5/20 0.76
▸ LMNA P02545 2/20 0.70
▸ L3MBTL1 Q9Y468 2/20 0.70
▸ KDM4E B2RXH2 1/20 0.70
▸ ALDH1A1 P00352 1/20 0.70
▸ HPGD P15428 1/20 0.70
▸ MAPK14 Q16539 11/20 0.61
▸ MAPK13 O15264 10/20 0.61
▸ MAPK12 P53778 10/20 0.61
▸ MAPK11 Q15759 10/20 0.61
▸ GCGR P47871 5/20 0.55
▸ RAF1 P04049 1/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ POLB P06746 1/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ GFER P55789 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3382433 0.82 KDM4E (1.00) PTGS1PTGS2LMNAL3MBTL1KDM4E
SCHEMBL11396176 0.82 PTGS1 (0.78) PTGS1PTGS2MAPK14
SCHEMBL11272419 0.80 ALDH1A1 (0.66) PTGS1PTGS2LMNAL3MBTL1KDM4E
Bromide SCHEMBL11178458 0.80 PTGS1 (0.60) PTGS1PTGS2KDM4EMAPK14MAPK13
SCHEMBL3956357 0.80 MAPK13 (0.74) PTGS1PTGS2MAPK14MAPK13MAPK12
SCHEMBL9748575 0.78 MAPK13 (0.83) MAPK14MAPK13MAPK12MAPK11GCGR
SCHEMBL7041734 0.77 KDM4E (0.67) PTGS1PTGS2KDM4EHPGDMAPK14
SCHEMBL13712659 0.76 MAPK14 (1.00) PTGS1PTGS2MAPK14MAPK13MAPK12
SCHEMBL4460547 0.76 MAPK14 (1.00) PTGS1PTGS2MAPK14MAPK13MAPK12
SCHEMBL10963418 0.76 MAPK14 (0.66) PTGS1PTGS2KDM4EMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0236628-B1 INHIBITION OF THE 5-LIPOXYGENASE PATHWAY SMITHKLINE BEECHAM CORPORATION (US) 1992-12-02 — — EP disclosed
US-4780470-A WITH 4,5-DIALKYL-2(SUBSTITUTED)IMIDAZOLE SMITHKLINE BECKMAN CORPORATION (US) 1988-10-25 — — US disclosed
US-4686231-A 4,5-DIARYL-2-SUBSTITUTED-IMIDAZOLE SMITHKLINE BECKMAN CORPORATION (US) 1987-08-11 — — US disclosed
EP-0008755-B1 ANTIINFLAMMATORY 4,5-DIARYL-2-NITROIMIDAZOLES, METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM E.I. DU PONT DE NEMOURS AND COMPANY (US) 1982-04-21 — — EP disclosed
EP-0011115-B1 ANTIINFLAMMATORY 2-SUBSTITUTED-1H-PHENANTHRO(9,10-D)IMIDAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM E.I. DU PONT DE NEMOURS AND COMPANY (US) 1982-01-20 — — EP disclosed
US-4251535-A ANTIARTHRITIC AGENTS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1981-02-17 — — US disclosed
US-4215135-A Antiinflammatory 2-substituted-1H-phenanthro[9,10-d]imidazoles E. I. DU PONT DE NEMOURS AND COMPANY (US) 1980-07-29 — — US disclosed
EP-0011115-A1 Antiinflammatory 2-substituted-1H-phenanthro(9,10-d)imidazoles, their preparation and pharmaceutical compositions containing them E.I. DU PONT DE NEMOURS AND COMPANY (US) 1980-05-28 — — EP disclosed
US-4199592-A Antiinflammatory 4,5-diaryl-2-nitroimidazoles E. I. DU PONT DE NEMOURS AND COMPANY (US) 1980-04-22 — — US disclosed
US-4198421-A ANTIARTHRITIC E. I. DU PONT DE NEMOURS AND COMPANY (US) 1980-04-15 — — US disclosed
EP-0008755-A1 Antiinflammatory 4,5-diaryl-2-nitroimidazoles, method for their preparation and pharmaceutical composition containing them E.I. DU PONT DE NEMOURS AND COMPANY (US) 1980-03-19 — — EP disclosed
US-4190666-A ANTIARTHRITIC, ANALGESIC E. I. DU PONT DE NEMOURS AND COMPANY (US) 1980-02-26 — — US disclosed
US-4182769-A ANALGESIC, ANTIARTHRITIC E. I. DU PONT DE NEMOURS AND COMPANY (US) 1980-01-08 — — US disclosed
US-4159338-A ANTIARTHRITIC, ANALGESIC E. I. DU PONT DE NEMOURS AND COMPANY (US) 1979-06-26 — — US disclosed
Send feedback